YM Biosciences
Industry: Company
DescriptionYM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a ... Founded: 1992 Headquarters: Toronto, Canada Successor: Gilead Sciences Founders: Tarrnie Williams, David Allan
YM Biosciences List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at YM Biosciences. You can filter them based on skills, years of employment, job, education, department, and prior employment.
YM Biosciences Salaries. You can even request information on how much does YM Biosciences pay if you want to. Learn about salaries, pros and cons of working for YM Biosciences directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
15 YM Biosciences employees in database. Find out everything there's to know about YM Biosciences employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
YM Biosciences Employees
Employee
Years
Job
Industry
Karen Jones Karen Jones's YM Biosciences Experience October 2002 - September 2011
Job Performing Singer/Songwriter
Industry Music
Experience
Karen and Amy Jones February 2006 - Present
The Beautiful Distortion June 2011 - Present
Emergent BioSolutions February 2014 - Present
Cangene Corporation January 2012 - February 2014
YM BioSciences October 2002 - September 2011
Skills
Songwriting, Singing, Harmony, Performing, Guitar, Opera, Sound, Songs, Vocal, Rock, Lyrics, Guitarist, Concerts, Musicians
Education
Penn State University 1993 — 1998
Vocal Performance
Eastman School of Music 1991 — 1992
Vocal Performance
Karen and Amy Jones February 2006 - Present
The Beautiful Distortion June 2011 - Present
Emergent BioSolutions February 2014 - Present
Cangene Corporation January 2012 - February 2014
YM BioSciences October 2002 - September 2011
Skills
Songwriting, Singing, Harmony, Performing, Guitar, Opera, Sound, Songs, Vocal, Rock, Lyrics, Guitarist, Concerts, Musicians
Education
Penn State University 1993 — 1998
Vocal Performance
Eastman School of Music 1991 — 1992
Vocal Performance
Alex Senson Alex Senson's YM Biosciences Experience June 2010 - March 2011
Job Business Analyst at the Research, Innovation and Commercialization Centre
Industry Biotechnology
Experience
Research, Innovation and Commercialization Centre May 2013 - Present
YM BioSciences Inc., Mississauga, ON (Gilead Sciences as of 9Feb13) April 2011 - March 2013
YM BioSciences June 2010 - March 2011
YM BioSciences January 2007 - May 2010
McMaster University May 2005 - April 2006
Skills
Drug Development, Biotechnology, Pharmaceutical Industry, Life Sciences, Oncology, Project Management, Business Analysis, Business Advisory, Report Writing, Entrepreneurship, Start-ups, Venture Financing, Strategy, Problem Solving, Presentations, Vendor Management, Commercialization, Due Diligence, Technology Transfer, Data Analysis, CMC, Market Analysis, Market Research, Business Strategy, Business Planning, Business Development, Lean Startup, Coaching, Science, Investments, Venture Capital, Technical Writing, Document Review, Business Process..., Performance Metrics, Cross-functional..., Salesforce.com, Microsoft Excel, Martial Arts, Karate
Education
University of Toronto 2006 — 2008
Master of Biotechnology (MBiotech), Biotechnology and Pharmaceutical Industry
McMaster University 2002 — 2006
H.BSc, Biochemistry, Genetic Engineering and Biotechnology
Research, Innovation and Commercialization Centre May 2013 - Present
YM BioSciences Inc., Mississauga, ON (Gilead Sciences as of 9Feb13) April 2011 - March 2013
YM BioSciences June 2010 - March 2011
YM BioSciences January 2007 - May 2010
McMaster University May 2005 - April 2006
Skills
Drug Development, Biotechnology, Pharmaceutical Industry, Life Sciences, Oncology, Project Management, Business Analysis, Business Advisory, Report Writing, Entrepreneurship, Start-ups, Venture Financing, Strategy, Problem Solving, Presentations, Vendor Management, Commercialization, Due Diligence, Technology Transfer, Data Analysis, CMC, Market Analysis, Market Research, Business Strategy, Business Planning, Business Development, Lean Startup, Coaching, Science, Investments, Venture Capital, Technical Writing, Document Review, Business Process..., Performance Metrics, Cross-functional..., Salesforce.com, Microsoft Excel, Martial Arts, Karate
Education
University of Toronto 2006 — 2008
Master of Biotechnology (MBiotech), Biotechnology and Pharmaceutical Industry
McMaster University 2002 — 2006
H.BSc, Biochemistry, Genetic Engineering and Biotechnology
Andrew Yoshioka Andrew Yoshioka's YM Biosciences Experience July 2009 - August 2010
Job President, Sanbonki Inc.
Industry Management Consulting
Experience
Sanbonki Inc. October 2011 - Present
Andrew Yoshioka Management Consulting September 2010 - October 2011
YM Biosciences July 2009 - August 2010
YM Biosciences September 2008 - July 2009
YM Biosciences October 2006 - September 2008
DELEX Therapeutics July 2001 - October 2006
GlaxoSmithKline January 2001 - June 2001
SmithKline Beecham March 1998 - December 2000
Bencard Allergy Laboratories (SmithKline Beecham) November 1996 - June 1998
SmithKline Beecham January 1995 - November 1996
Skills
Biotechnology, Commercialization, Strategic Planning, Pharmaceutical Industry, Drug Development, CRO, Due Diligence, GCP, Regulatory Affairs, GMP, Biotechnology Industry, Mergers & Acquisitions, Operational Efficiency, Biopharmaceuticals, Clinical Research, Technology Transfer, Vaccines, Value Creation, Mentoring, Turn Around Management, Business Networking, Oncology, Management, Leadership, Lifesciences, Corporate turn-around, Management Coaching, Strategic Insights, Connecting People, Driving Results, Volunteering, Increasing Operational..., Life Sciences
Education
McGill University 1982 — 1984
BSc, Biochemistry
Dalhousie University 1979 — 1982
Undergraduate Science
Sanbonki Inc. October 2011 - Present
Andrew Yoshioka Management Consulting September 2010 - October 2011
YM Biosciences July 2009 - August 2010
YM Biosciences September 2008 - July 2009
YM Biosciences October 2006 - September 2008
DELEX Therapeutics July 2001 - October 2006
GlaxoSmithKline January 2001 - June 2001
SmithKline Beecham March 1998 - December 2000
Bencard Allergy Laboratories (SmithKline Beecham) November 1996 - June 1998
SmithKline Beecham January 1995 - November 1996
Skills
Biotechnology, Commercialization, Strategic Planning, Pharmaceutical Industry, Drug Development, CRO, Due Diligence, GCP, Regulatory Affairs, GMP, Biotechnology Industry, Mergers & Acquisitions, Operational Efficiency, Biopharmaceuticals, Clinical Research, Technology Transfer, Vaccines, Value Creation, Mentoring, Turn Around Management, Business Networking, Oncology, Management, Leadership, Lifesciences, Corporate turn-around, Management Coaching, Strategic Insights, Connecting People, Driving Results, Volunteering, Increasing Operational..., Life Sciences
Education
McGill University 1982 — 1984
BSc, Biochemistry
Dalhousie University 1979 — 1982
Undergraduate Science
Leigh Revers's YM Biosciences Experience November 2008 - January 2012
Job Chief Executive Officer at D5Pharma Inc.
Industry Biotechnology
Experience
D5Pharma Inc. May 2014 - Present
University of Toronto July 2013 - Present
D5Pharma Inc. 2011 - Present
AdamsRevers January 2007 - Present
University of Toronto May 2006 - Present
YM Biosciences November 2008 - January 2012
Molecular Templates Inc. 2004 - February 2011
University Health Network 2004 - 2007
University Health Network 2000 - 2004
University Health Network March 1999 - October 2001
Skills
Pharmaceutical Industry, Lifesciences, Oncology, Biotechnology, Molecular Biology, Organic Chemistry, Protein Chemistry, Protein Expression, Protein Engineering, Drug Discovery, Drug Delivery, Drug Development, Molecular Cloning, PCR, Entrepreneurship, Genetics, Cell, Cell Culture, Biopharmaceuticals, Chemistry, Cancer
Education
University of Oxford 1988 — 1996
Doctor of Philosophy (Ph.D.), Physical Sciences
Warwick School 1980 — 1988
D5Pharma Inc. May 2014 - Present
University of Toronto July 2013 - Present
D5Pharma Inc. 2011 - Present
AdamsRevers January 2007 - Present
University of Toronto May 2006 - Present
YM Biosciences November 2008 - January 2012
Molecular Templates Inc. 2004 - February 2011
University Health Network 2004 - 2007
University Health Network 2000 - 2004
University Health Network March 1999 - October 2001
Skills
Pharmaceutical Industry, Lifesciences, Oncology, Biotechnology, Molecular Biology, Organic Chemistry, Protein Chemistry, Protein Expression, Protein Engineering, Drug Discovery, Drug Delivery, Drug Development, Molecular Cloning, PCR, Entrepreneurship, Genetics, Cell, Cell Culture, Biopharmaceuticals, Chemistry, Cancer
Education
University of Oxford 1988 — 1996
Doctor of Philosophy (Ph.D.), Physical Sciences
Warwick School 1980 — 1988
Nicola Thorne (Jones) Nicola Thorne (Jones)'s YM Biosciences Experience November 2010 - May 2013
Job Project Director at Chiltern International
Industry Biotechnology
Experience
Chiltern January 2015 - Present
Chiltern International April 2014 - January 2015
Chiltern International May 2013 - April 2014
YM Biosciences November 2010 - May 2013
Adiga Life Sciences Inc. March 2010 - November 2010
Viventia Biotechnologies Inc. March 2006 - March 2010
MDS Pharma Services September 2001 - February 2006
Skills
Clinical Trials, CRO, GCP, Clinical Development, CTMS, ICH-GCP, Oncology, Clinical Monitoring, Pharmaceutical Industry, Biotechnology, Immunology, Hematology, Cancer, CRF design, Trial Management, Protocol
Education
McMaster University 1996 — 2000
Chiltern January 2015 - Present
Chiltern International April 2014 - January 2015
Chiltern International May 2013 - April 2014
YM Biosciences November 2010 - May 2013
Adiga Life Sciences Inc. March 2010 - November 2010
Viventia Biotechnologies Inc. March 2006 - March 2010
MDS Pharma Services September 2001 - February 2006
Skills
Clinical Trials, CRO, GCP, Clinical Development, CTMS, ICH-GCP, Oncology, Clinical Monitoring, Pharmaceutical Industry, Biotechnology, Immunology, Hematology, Cancer, CRF design, Trial Management, Protocol
Education
McMaster University 1996 — 2000
Denis Bosc Denis Bosc's YM Biosciences Experience October 2012 - February 2013
Job Senior Director Scientific Affairs at STERIMAX INC.
Industry Pharmaceuticals
Experience
STERIMAX INC. January 2014 - Present
Apotex Inc. June 2013 - December 2013
YM BioSciences October 2012 - February 2013
YM Biosciences Inc August 2010 - October 2012
SQI Diagnostics August 2008 - August 2010
Viventia Biotech January 2007 - August 2008
Viventia Biotech January 2005 - December 2006
Viventia Biotech Inc. January 2004 - January 2005
Viventia Biotech April 2002 - December 2003
Skills
GMP, Clinical Development, Chemistry, Purification, Process Simulation, Formulation, Technology Transfer, Biopharmaceuticals, Biotechnology, Lifesciences, FDA, GLP, Pharmaceutical Industry, Drug Development, Quality System, Validation, Protein Chemistry, Assay Development, Microbiology
Education
RAPS
University of Manitoba
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology
STERIMAX INC. January 2014 - Present
Apotex Inc. June 2013 - December 2013
YM BioSciences October 2012 - February 2013
YM Biosciences Inc August 2010 - October 2012
SQI Diagnostics August 2008 - August 2010
Viventia Biotech January 2007 - August 2008
Viventia Biotech January 2005 - December 2006
Viventia Biotech Inc. January 2004 - January 2005
Viventia Biotech April 2002 - December 2003
Skills
GMP, Clinical Development, Chemistry, Purification, Process Simulation, Formulation, Technology Transfer, Biopharmaceuticals, Biotechnology, Lifesciences, FDA, GLP, Pharmaceutical Industry, Drug Development, Quality System, Validation, Protein Chemistry, Assay Development, Microbiology
Education
RAPS
University of Manitoba
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology
Swarna Mathi's YM Biosciences Experience April 2010 - Present
Job Senior Clinical Project Manager at YM BioSciences
Industry Pharmaceuticals
Experience
YM BioSciences April 2010 - Present
Bradmer Pharmaceuticals July 2008 - March 2009
ConjuChem Biotechnologies October 2003 - April 2007
MDS Pharma Services April 2003 - October 2003
Skills
CRO, Oncology, Clinical Research, Biotechnology, Sop, Therapeutic Areas, Diabetes, Clinical Study Design, Cancer, Protocol, Data Management, Drug Safety
Education
Queen's University
Ph.D., Molecular Biology
University of Toronto
M.Sc., Developmental Biology
YM BioSciences April 2010 - Present
Bradmer Pharmaceuticals July 2008 - March 2009
ConjuChem Biotechnologies October 2003 - April 2007
MDS Pharma Services April 2003 - October 2003
Skills
CRO, Oncology, Clinical Research, Biotechnology, Sop, Therapeutic Areas, Diabetes, Clinical Study Design, Cancer, Protocol, Data Management, Drug Safety
Education
Queen's University
Ph.D., Molecular Biology
University of Toronto
M.Sc., Developmental Biology
Rick Lampe's YM Biosciences Experience January 2008 - August 2008
Job Contract Regulator at AstraZeneca Pharmaceuticals
Industry Pharmaceuticals
Experience
Avraham Pharmaceuticals Ltd Contract RegulatorAstraZeneca PharmaceuticalsMay 2014 - Present
CliniRx Research Pvt. Ltd. January 2013 - May 2014
Varinel LDC October 2008 - April 2012
YM Biosciences January 2008 - August 2008
New River Pharmaceuticals February 2006 - August 2007
Eximias Pharmaceuticial Corp June 2004 - November 2005
AstraZeneca Pharmaceuticals June 2000 - June 2004
ICI / Zeneca Pharmaceuticals June 1989 - June 2000
E.I. DuPont de Nemours 1981 - 1989
Skills
Biologics, Sop, GxP, Biotechnology, Medical Devices, CRO, Medical Affairs, Pharmaceutical Industry, Regulatory Affairs, LIMS, Drug Development, Clinical Development, Formulation, Infectious Diseases, CMC, ICH-GCP, Molecular Biology, Biomarkers, Oncology, Regulatory Submissions, GLP, Medical Writing, EDC, NDA, Clinical Data Management, Regulatory Requirements, Chromatography, GMP, HPLC, Drug Discovery, IND, Market Access, Analytical Chemistry, Clinical Trials, CAPA, 21 CFR Part 11, Technology Transfer, Quality System, In Vitro, Pharmacology, V&V, Biochemistry, Biopharmaceuticals, CTMS, Immunology, Change Control, Clinical Monitoring, Therapeutic Areas, Vaccines, Pharmacovigilance
Education
The University of Kansas 1978 — 1981
MS, Biochemistry
University of Virginia 1971 — 1975
BA, Psychology, Philosophy
Avraham Pharmaceuticals Ltd Contract RegulatorAstraZeneca PharmaceuticalsMay 2014 - Present
CliniRx Research Pvt. Ltd. January 2013 - May 2014
Varinel LDC October 2008 - April 2012
YM Biosciences January 2008 - August 2008
New River Pharmaceuticals February 2006 - August 2007
Eximias Pharmaceuticial Corp June 2004 - November 2005
AstraZeneca Pharmaceuticals June 2000 - June 2004
ICI / Zeneca Pharmaceuticals June 1989 - June 2000
E.I. DuPont de Nemours 1981 - 1989
Skills
Biologics, Sop, GxP, Biotechnology, Medical Devices, CRO, Medical Affairs, Pharmaceutical Industry, Regulatory Affairs, LIMS, Drug Development, Clinical Development, Formulation, Infectious Diseases, CMC, ICH-GCP, Molecular Biology, Biomarkers, Oncology, Regulatory Submissions, GLP, Medical Writing, EDC, NDA, Clinical Data Management, Regulatory Requirements, Chromatography, GMP, HPLC, Drug Discovery, IND, Market Access, Analytical Chemistry, Clinical Trials, CAPA, 21 CFR Part 11, Technology Transfer, Quality System, In Vitro, Pharmacology, V&V, Biochemistry, Biopharmaceuticals, CTMS, Immunology, Change Control, Clinical Monitoring, Therapeutic Areas, Vaccines, Pharmacovigilance
Education
The University of Kansas 1978 — 1981
MS, Biochemistry
University of Virginia 1971 — 1975
BA, Psychology, Philosophy
Ralph Schatzmair's YM Biosciences Experience 2002 - 2005
Job President at RKS Medical Technologies
Industry Medical Devices
Experience
RKS Medical Technologies 2009 - Present
CardioComm Solutions Inc. 2008 - 2009
IsoRay Medical 2005 - 2007
YM BioSciences 2002 - 2005
Yorkton Securities 1996 - 2002
Midland Walwyn 1991 - 1996
Skills
Business Development, Medical Devices, Investor Relations, Corporate Development, Hospitals, Mergers, Healthcare, Medical Imaging, Strategic Planning, Oncology, Project Management, IPO, Corporate Finance, PACS
Education
McMaster University 1980 — 1983
BA, Commerce
RKS Medical Technologies 2009 - Present
CardioComm Solutions Inc. 2008 - 2009
IsoRay Medical 2005 - 2007
YM BioSciences 2002 - 2005
Yorkton Securities 1996 - 2002
Midland Walwyn 1991 - 1996
Skills
Business Development, Medical Devices, Investor Relations, Corporate Development, Hospitals, Mergers, Healthcare, Medical Imaging, Strategic Planning, Oncology, Project Management, IPO, Corporate Finance, PACS
Education
McMaster University 1980 — 1983
BA, Commerce
C. Scott Bentham's YM Biosciences Experience May 2005 - February 2013
Job Pharmaceutical Development Professional
Industry Pharmaceuticals
Experience
Gilead Sciences February 2013 - March 2013
YM Biosciences May 2005 - February 2013
Bristol-Myers Squibb 1994 - 2004
Skills
Pharmaceutical Industry, Technology Transfer, FDA, GMP, Biopharmaceuticals, Biotechnology, Lifesciences, Drug Development, Validation, Regulatory Affairs, Sop, HPLC, GLP, Clinical Development, 21 CFR Part 11, Vaccines, Formulation, Commercialization, Regulatory Submissions, CRO, Drug Discovery, GxP, Chemical Engineering,..., Process Simulation, Contract Manufacturing, CAPA, GCP, Protein Chemistry, Clinical Trials
Education
Syracuse University
Master of Science, Chemical Engineering
State University of New York at Buffalo 1991 — 1993
Bachelor of Science, Chemical Engineering
Alfred State College - SUNY College of Technology
Alfred State College - SUNY College of Technology
Gilead Sciences February 2013 - March 2013
YM Biosciences May 2005 - February 2013
Bristol-Myers Squibb 1994 - 2004
Skills
Pharmaceutical Industry, Technology Transfer, FDA, GMP, Biopharmaceuticals, Biotechnology, Lifesciences, Drug Development, Validation, Regulatory Affairs, Sop, HPLC, GLP, Clinical Development, 21 CFR Part 11, Vaccines, Formulation, Commercialization, Regulatory Submissions, CRO, Drug Discovery, GxP, Chemical Engineering,..., Process Simulation, Contract Manufacturing, CAPA, GCP, Protein Chemistry, Clinical Trials
Education
Syracuse University
Master of Science, Chemical Engineering
State University of New York at Buffalo 1991 — 1993
Bachelor of Science, Chemical Engineering
Alfred State College - SUNY College of Technology
Alfred State College - SUNY College of Technology
Niclas Stiernholm's YM Biosciences Experience May 2000 - October 2002
Job President & CEO at Trillium Therapeutics
Industry Biotechnology
Experience
Trillium Therapeutics Inc April 2013 - Present
Trillium Therapeutics October 2002 - April 2013
YM Biosciences May 2000 - October 2002
Allelix Biopharmaceuticals Inc. 1997 - 1999
Education
Elon University
BA, Biology/Chemistry
University of Toronto
Ph.D., Immunology
Trillium Therapeutics Inc April 2013 - Present
Trillium Therapeutics October 2002 - April 2013
YM Biosciences May 2000 - October 2002
Allelix Biopharmaceuticals Inc. 1997 - 1999
Education
Elon University
BA, Biology/Chemistry
University of Toronto
Ph.D., Immunology
Peter Donovan's YM Biosciences Experience October 2008 - Present
Job It securiyi at PricewaterhouseCoopers
Industry Information Technology and Services
Experience
YM Biosciences October 2008 - Present
IBM March 2004 - October 2006
Education
Indiana Institute of Technology
M.S.C.S., Computer and Network security
YM Biosciences October 2008 - Present
IBM March 2004 - October 2006
Education
Indiana Institute of Technology
M.S.C.S., Computer and Network security
Deloitte
PwC
Ernst & Young
Walgreens
Procter & Gamble
KPMG
PricewaterhouseCoopers
EY